1. Home
  2. MLAB vs CEP Comparison

MLAB vs CEP Comparison

Compare MLAB & CEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • CEP
  • Stock Information
  • Founded
  • MLAB 1982
  • CEP 2020
  • Country
  • MLAB United States
  • CEP United States
  • Employees
  • MLAB N/A
  • CEP N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • CEP
  • Sector
  • MLAB Industrials
  • CEP
  • Exchange
  • MLAB Nasdaq
  • CEP NYSE
  • Market Cap
  • MLAB 524.2M
  • CEP 516.2M
  • IPO Year
  • MLAB N/A
  • CEP 2024
  • Fundamental
  • Price
  • MLAB $95.82
  • CEP $33.20
  • Analyst Decision
  • MLAB Hold
  • CEP
  • Analyst Count
  • MLAB 2
  • CEP 0
  • Target Price
  • MLAB $130.00
  • CEP N/A
  • AVG Volume (30 Days)
  • MLAB 126.1K
  • CEP 1.1M
  • Earning Date
  • MLAB 08-04-2025
  • CEP 01-01-0001
  • Dividend Yield
  • MLAB 0.67%
  • CEP N/A
  • EPS Growth
  • MLAB N/A
  • CEP N/A
  • EPS
  • MLAB N/A
  • CEP 0.25
  • Revenue
  • MLAB $240,978,000.00
  • CEP N/A
  • Revenue This Year
  • MLAB $6.28
  • CEP N/A
  • Revenue Next Year
  • MLAB $5.93
  • CEP N/A
  • P/E Ratio
  • MLAB N/A
  • CEP $131.51
  • Revenue Growth
  • MLAB 11.47
  • CEP N/A
  • 52 Week Low
  • MLAB $83.68
  • CEP $9.99
  • 52 Week High
  • MLAB $155.12
  • CEP $59.75
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 36.61
  • CEP N/A
  • Support Level
  • MLAB $87.80
  • CEP N/A
  • Resistance Level
  • MLAB $105.59
  • CEP N/A
  • Average True Range (ATR)
  • MLAB 4.00
  • CEP 0.00
  • MACD
  • MLAB -0.44
  • CEP 0.00
  • Stochastic Oscillator
  • MLAB 43.12
  • CEP 0.00

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About CEP CANTOR EQUITY PARTNERS INC

Cantor Equity Partners Inc is a blank check company.

Share on Social Networks: